Pharmaceutical giant AbbVie on Wednesday announced it was teaming up with Google-funded Calico, the life sciences initiative aimed at helping patients deal with diseases and other negative effects associated with aging. Under the terms of the partnership, both AbbVie and Calico will invest up to $250 million in the project, with the possibility of another $500 million each. That money will go toward understanding and fighting diseases such as cancer or neurodegenerative disorders that are common in the aging population.Big Pharma Joins Google's Quest for Aging Antidote
Pharmaceutical giant AbbVie on Wednesday announced it was teaming up with Google-funded Calico, the life sciences initiative aimed at helping patients deal with diseases and other negative effects associated with aging. Under the terms of the partnership, both AbbVie and Calico will invest up to $250 million in the project, with the possibility of another $500 million each. That money will go toward understanding and fighting diseases such as cancer or neurodegenerative disorders that are common in the aging population.
0 comments:
Post a Comment